DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today financial results for the fourth quarter and year ended December 31, 2006, reporting a net loss of $15.5 million, or ($0.37) per share, for the fourth quarter, and a net loss of $42.1 million, or ($1.00) per share, for the full year.
